Skip to Main Content

Paper Details

The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models.
Int J Mol Sci
4
2016
Author NameAffiliation
Verena SailerInstitut fur Pathologie, Universitatsmedizin Greifswald
Verena SailerEnglander Institut for Precision Medicine, Weill Cornell University of Medicine
  • 1 - 2

Datasets